← Eichor
Condition: Pediatric Cancer Patients Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Pediatric Cancer Patients

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07043894A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considerin
NA · 1 location(s) · Columbia University · NCT05963971The MARVIN Chatbots to Provide Information for Different Health Conditions
NA · 2 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT05789901Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indi
NA · 1 location(s) · St. Jude Children's Research Hospital · NCT04764357Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Phase 2 · 24 location(s) · Novartis Pharmaceuticals · NCT07354074Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Phase 1 · 31 location(s) · Therapeutic Advances in Childhood Leukemia Consortium · NCT05476770Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG
EARLY_Phase 1 · 1 location(s) · Children's Hospital of Philadelphia · NCT05555550Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Ome
Phase N/A · 10 location(s) · Fresenius Kabi · NCT06274788CD7-CAR-T Cells in Pediatric Relapsed/Refractory CD7+ T-ALL/LL
Phase 1/Phase 2 · 1 location(s) · Bambino Gesù Hospital and Research Institute · NCT06064903Massage Impact on Sleep in Pediatric Oncology
NA · 2 location(s) · Children's Hospital of Philadelphia · NCT06892158An International Study on Pediatric Patients With Rare Tumors.
Phase N/A · 1 location(s) · Azienda Ospedaliera di Padova · NCT07072143Nalbuphine Versus Tramadol on Post Operative Analgesia in Abdominal Surgery on Pediatric Cancer Patient
NA · 1 location(s) · National Cancer Institute, Egypt · NCT07110051A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic
Phase 1 · 8 location(s) · Autolus Limited · NCT06173518Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory
Phase 1 · 2 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT03721068Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors
NA · 1 location(s) · Washington University School of Medicine · NCT05582551A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patien
Phase 3 · 29 location(s) · Children's Oncology Group · NCT05711667Children's Laughter and Fun Yoga as Adjunctive Pain Relief Following Chemotherapy.
NA · 1 location(s) · Bahaa Bou Dargham · NCT07327138A Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric)
Phase 1/Phase 2 · 9 location(s) · Juventas Cell Therapy Ltd. · NCT05667506Proof-of-Concept Study of the SNOEZELEN Device on Anxiety Symptoms in Patients Hospitalized for Chemotherapy in a Pediat
NA · 1 location(s) · Centre Oscar Lambret · NCT07202507Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Phase 2 · 5 location(s) · Children's Hospital of Philadelphia · NCT05783323Targeted Therapy to Increase RAI Uptake in Metastatic DTC
Phase N/A · 9 location(s) · Children's Hospital of Philadelphia · NCT05024929Decision Support Intervention of Minor Cancer Patients and Their Parents
NA · 1 location(s) · Kaohsiung Medical University Chung-Ho Memorial Hospital · NCT06651242Combined Immuno-chemotherapy for Patients With B-linear Acute Lymphoblastic Leukemia Diagnosed From 0 to 365 Days of Lif
Phase 3 · 1 location(s) · Federal Research Institute of Pediatric Hematology, Oncology · NCT05029531LOG-I - Impact Study of LOG-AFTER Software on Long-term Monitoring of Former Patients (LOG-I - LOG-Impact Study)
NA · 1 location(s) · University Hospital, Angers · NCT06939322Safety and Efficacy of CAR T Cell Therapy in Patients with R/r B-ALL
Phase 1/Phase 2 · 1 location(s) · Kara Yakhteh Tajhiz Azma Company · NCT06635330Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
Phase 2 · 5 location(s) · Children's Hospital of Philadelphia · NCT06458036Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors
Phase 1/Phase 2 · 2 location(s) · Princess Maxima Center for Pediatric Oncology · NCT04925609Early Pulmonary Dysfunction in Childhood Cancer Patients
Phase N/A · 5 location(s) · University Children's Hospital Basel · NCT05427136UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL
Phase 1/Phase 2 · 1 location(s) · University of Colorado, Denver · NCT04544592Response to Influenza Vaccination in Pediatric Oncology Patients
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT05384288
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.